FINAL 02/04/2026 Financial Supplement Fourth Quarter 2025 This document is a statistical supplement to Aflac's quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document. The Company adopted the Financial Accounting Standards Board's Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accoun ...

Core Insights - Aflac Incorporated reported a decline in total revenues and net earnings for the fourth quarter and full year of 2025 compared to 2024, indicating challenges in financial performance [1][5][18]. Financial Performance - Total revenues for Q4 2025 were $4.9 billion, down from $5.4 billion in Q4 2024, representing a decrease of 9.9% [1][25]. - Net earnings for Q4 2025 were $1.4 billion, or $2.64 per diluted share, compared to $1.9 billion, or $3.42 per diluted share in Q4 2024, reflecting a decline of 27.5% [1][26]. - For the full year 2025, total revenues decreased by 9.3% to $17.2 billion from $18.9 billion in 2024 [5][25]. - Net earnings for the full year 2025 were $3.6 billion, or $6.82 per diluted share, down from $5.4 billion, or $9.63 per diluted share in 2024, marking a 33.0% decline [5][26]. Investment Gains - Q4 2025 net investment gains were $537 million, or $1.03 per diluted share, compared to $1.0 billion, or $1.86 per diluted share in Q4 2024 [2][32]. - The investment gains were influenced by net gains on derivatives and foreign currency activities, alongside losses from sales and redemptions [2]. Adjusted Earnings - Adjusted earnings for Q4 2025 were $818 million, down 5.4% from $865 million in Q4 2024 [3][32]. - Adjusted earnings per diluted share increased by 0.6% to $1.57 in Q4 2025 [3][32]. - For the full year 2025, adjusted earnings were $4.0 billion, or $7.49 per diluted share, compared to $4.1 billion, or $7.21 per diluted share in 2024, reflecting a slight decrease of 1.6% [5][34]. Shareholders' Equity - Shareholders' equity at the end of Q4 2025 was $29.5 billion, or $56.85 per share, up from $26.1 billion, or $47.45 per share at the end of Q4 2024 [4][37]. - The increase in shareholders' equity was attributed to changes in discount rate assumptions on insurance reserves [4]. Aflac Japan Performance - In yen terms, Aflac Japan's net earned premiums for Q4 2025 were ¥252.6 billion, a decrease of 1.9% year-over-year [7][8]. - Adjusted net investment income in yen decreased by 3.9% to ¥97.4 billion [7]. - For the full year, net earned premiums in yen were ¥1.0 trillion, down 3.9% from the previous year [8]. Aflac U.S. Performance - Aflac U.S. net earned premiums increased by 4.0% to $1.5 billion in Q4 2025, reflecting improved sales [12][13]. - Total adjusted revenues for Aflac U.S. were up 3.3% to $1.7 billion in Q4 2025 [12]. - For the full year, net earned premiums increased by 2.9% to $6.0 billion [13]. Capital Management - The board declared a first-quarter dividend of $0.61 per share, payable on March 2, 2026 [17]. - Aflac repurchased $800 million worth of shares in Q4 2025, with a total of $3.5 billion in share repurchases for the year [17][22].

Senior Executive Vice President CFO, Aflac Incorporated Fourth Quarter 2025 Update Max K. Brodén Forward-Looking Information and Non-U.S. GAAP Financial Measures The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materiall ...

Core Insights - Aflac Incorporated will have President Virgil R. Miller participate in a fireside chat at the UBS Financial Services Conference on February 11, 2026, at 9:40 a.m. ET, which will be webcast live [1] Company Overview - Aflac Incorporated is a Fortune 500 company that has provided financial protection for over 70 years to millions of policyholders through its subsidiaries in the U.S. and Japan [2] - In the U.S., Aflac is the leading provider of supplemental health insurance products, while in Japan, Aflac Life Insurance Japan is the top provider of cancer and medical insurance based on policies in force [2] - The company has been recognized as one of the World's Most Ethical Companies for 19 consecutive years and has been included in Fortune's World's Most Admired Companies for 24 years [2] - Aflac became a signatory of the Principles for Responsible Investment in 2021 and has been part of the Dow Jones Sustainability North America Index for 11 years [2] Event Information - A replay of the presentation will be available within 24 hours after the live event [2]

Aflac Incorporated (NYSE:AFL) is included among the Dividend Growth Stocks: 25 Aristocrats. TD Cowen Reviews Aflac (AFL) Ahead of Q4 Life Insurance Preview On January 28, TD Cowen trimmed its price target on Aflac Incorporated (NYSE:AFL) to $100 from $102 and kept a Hold rating. The change was part of a broader fourth-quarter preview across the life insurance group. TD Cowen said it expects a modest headwind from lower returns on alternative investments but continues to take a balanced view on the sector ...

Core Insights - Aflac Incorporated (AFL) is scheduled to report its fourth-quarter 2025 results on February 4, 2026, with earnings estimated at $1.71 per share and revenues at $4.48 billion [1] Earnings Estimates - The fourth-quarter earnings estimate has decreased by $0.01 over the past month, but still reflects a year-over-year increase of 9.6%. Quarterly revenues are projected to grow by 3.8% year-over-year [2] - For the full year 2025, Aflac's revenue estimate stands at $17.72 billion, indicating a decline of 0.6% year-over-year, while the EPS estimate is $7.63, suggesting a growth of 5.8% year-over-year [3] Earnings Prediction Model - The current model does not predict an earnings beat for Aflac, as it has an Earnings ESP of -3.12% and a Zacks Rank of 4 (Sell) [4] Factors Influencing Q4 Results - Aflac is expected to report Q4 EPS of $1.71 on $4.48 billion revenue, indicating 9.6% earnings growth and 3.8% sales growth. Net earned premiums are anticipated to rise by 3%, with U.S. revenues increasing by 5.1% and Japan by 1% [7] - The total benefit to premium ratio for Aflac Japan is projected at 64.7, down from 66.5 a year ago, with a 3.4% growth in pre-tax adjusted earnings. However, the U.S. benefit to premium ratio is expected to rise to 48.9 from 46.3, with a projected 7.1% decline in pre-tax adjusted earnings [9] - Aflac's net investment income is expected to decline by 5% year-over-year, which may offset some positive factors, making an earnings beat uncertain [10] Peer Performance - Marsh & McLennan reported Q4 adjusted EPS of $2.12, exceeding estimates by 7.6% due to growth in Risk and Insurance Services [11] - Aon reported Q4 adjusted earnings of $4.85 per share, surpassing estimates by 1.9%, driven by organic revenue growth and high retention rates [12] - Hartford Insurance reported Q4 adjusted operating earnings of $4.06 per share, exceeding estimates by 27.9%, supported by higher net investment income and improved loss ratios [13]

Analysts on Wall Street project that Aflac (AFL) will announce quarterly earnings of $1.71 per share in its forthcoming report, representing an increase of 9.6% year over year. Revenues are projected to reach $4.48 billion, increasing 3.8% from the same quarter last year.Over the last 30 days, there has been a downward revision of 1.1% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over ...

The market expects Aflac (AFL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on F ...

Core Insights - Albert Anthony is a Croatian-American business author and analyst contributing to Seeking Alpha with over 1,000 followers [1] - He has authored a book titled "Real Estate Investment Trusts (REITs): A Fundamental Analysis (2026 Edition)" available on Amazon [1] - Anthony has a background in business and information systems, having worked at Charles Schwab in the IT department [1] - He operates his own equities research firm, Albert Anthony & Company, remotely from Texas [1] - The author has participated in numerous business and innovation conferences and has hosted a program for Online Live TV Croatia [1] - He holds a B.A. in Political Science and various certifications including Microsoft Fundamentals and Risk Management specialization from CFI [1] - Anthony is also active on YouTube discussing REITs, reflecting his personal investment interests [1] Company and Industry Summary - Albert Anthony & Company is a Texas-registered boutique equities research firm managed entirely by Anthony [1] - The firm focuses on providing general market commentary and research based on publicly available data [1] - The author does not engage with non-publicly traded companies, small cap stocks, or startup CEOs, indicating a focus on established market entities [1] - The firm does not provide personalized financial advisory services or manage client funds, emphasizing a research-oriented approach [1]

Core Insights - Aflac Incorporated (AFL) has announced a strategic partnership with Workday Wellness to integrate its supplemental health solutions into the Workday platform, enhancing employer benefits offerings through AI-driven insights [1][8] Group 1: Partnership and Platform Overview - Workday Wellness is an AI-driven platform that provides real-time insights into employee benefits and wellness programs, aimed at improving administrative efficiency and engagement [2] - The partnership addresses a significant challenge in employee benefits, as highlighted by the 2025-2026 Aflac Workforces Report, which indicates that many employees lack understanding of their benefit options [3][4] Group 2: Benefits of the Partnership - The integration of Aflac's supplemental health solutions into Workday Wellness is expected to increase customer satisfaction and utilization of Aflac's products, potentially attracting new customers and retaining existing ones [5] - Aflac's supplemental products offer financial protection against out-of-pocket expenses not covered by primary insurance, including a variety of offerings such as cancer, accident, and critical illness insurance [6] Group 3: Market Performance - Aflac's shares have increased by 8.1% over the past six months, outperforming the industry growth of 6.3% [7]